Back to results
CompletedPhase 2

Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease

NCT00325728

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Alabaster, Alabama, United States

+71 additional locations

View on ClinicalTrials.gov
Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease — TrialFind